Determinants of response to frusemide in normal subjects. 1977

R A Branch, and C J Roberts, and M Homeida, and D Levine

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D004231 Diuresis An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Diureses
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

R A Branch, and C J Roberts, and M Homeida, and D Levine
January 1984, European journal of clinical pharmacology,
R A Branch, and C J Roberts, and M Homeida, and D Levine
August 1975, British journal of clinical pharmacology,
R A Branch, and C J Roberts, and M Homeida, and D Levine
July 1984, British journal of clinical pharmacology,
R A Branch, and C J Roberts, and M Homeida, and D Levine
July 1972, Clinical science,
R A Branch, and C J Roberts, and M Homeida, and D Levine
June 1993, The European respiratory journal,
R A Branch, and C J Roberts, and M Homeida, and D Levine
November 1964, Lancet (London, England),
R A Branch, and C J Roberts, and M Homeida, and D Levine
May 1984, British journal of clinical pharmacology,
R A Branch, and C J Roberts, and M Homeida, and D Levine
May 1970, Archives internationales de pharmacodynamie et de therapie,
R A Branch, and C J Roberts, and M Homeida, and D Levine
July 1986, Archives of physical medicine and rehabilitation,
R A Branch, and C J Roberts, and M Homeida, and D Levine
February 1965, Lancet (London, England),
Copied contents to your clipboard!